{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:38:36Z","timestamp":1790545116770,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.clinbiochem.2009.09.028","type":"journal-article","created":{"date-parts":[[2009,10,13]],"date-time":"2009-10-13T04:27:01Z","timestamp":1255408021000},"page":"124-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Soluble urokinase-type plasminogen activator receptor forms in plasma as markers of atherosclerotic plaque vulnerability"],"prefix":"10.1016","volume":"43","author":[{"given":"Fredrik J.","family":"Olson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine","family":"Thurison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Ryndel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunilla","family":"H\u00f8yer-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Fagerberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2009.09.028_bib1","doi-asserted-by":"crossref","first-page":"15S","DOI":"10.1016\/S0735-1097(02)02834-6","article-title":"Mechanisms of plaque vulnerability and rupture","volume":"41","author":"Shah","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/01.mbc.0000114441.59147.56","article-title":"Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic lesions","volume":"15","author":"Steins","year":"2004","journal-title":"Blood. Coagul. Fibrinolysis."},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.atherosclerosis.2004.07.031","article-title":"Identification of genes predominantly expressed in human macrophages","volume":"177","author":"Svensson","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib4","first-page":"459","article-title":"Urokinase-type plasminogen activator receptor is associated with macrophages and plaque rupture in symptomatic carotid atherosclerosis","volume":"22","author":"Svensson","year":"2008","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib5","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/S0021-9258(18)52382-6","article-title":"Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol","volume":"266","author":"Ploug","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0065-2423(07)44003-3","article-title":"Urokinase receptor variants in tissue and body fluids","volume":"44","author":"Hoyer-Hansen","year":"2007","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib7","doi-asserted-by":"crossref","first-page":"18224","DOI":"10.1016\/S0021-9258(19)37176-5","article-title":"Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain","volume":"267","author":"Hoyer-Hansen","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1042\/bj3580673","article-title":"Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor","volume":"358","author":"Hoyer-Hansen","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib9","first-page":"7126","article-title":"Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy","volume":"60","author":"Mustjoki","year":"2000","journal-title":"Cancer. Res."},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib10","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1373\/clinchem.2004.038232","article-title":"Specific immunoassays for detection of intact and cleaved forms of the urokinase receptor","volume":"50","author":"Piironen","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0014-5793(00)01624-0","article-title":"Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivo","volume":"475","author":"Sidenius","year":"2000","journal-title":"FEBS. Lett."},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib12","first-page":"1132","article-title":"Prognostic significance of soluble urokinase plasminogen activator receptor in serum and cytosol of tumor tissue from patients with primary breast cancer","volume":"8","author":"Riisbro","year":"2002","journal-title":"Clin. Cancer. Res."},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib13","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/jnci\/91.10.869","article-title":"Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis","volume":"91","author":"Stephens","year":"1999","journal-title":"J. Natl. Cancer. Inst."},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib14","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1158\/1078-0432.CCR-08-0096","article-title":"Cleaved forms of the urokinase plasminogen activator receptor in plasma have diagnostic potential and predict postoperative survival in patients with ovarian cancer","volume":"14","author":"Henic","year":"2008","journal-title":"Clin. Cancer. Res."},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib15","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1373\/clinchem.2005.064253","article-title":"Enhanced discrimination of benign from malignant prostatic disease by selective measurements of cleaved forms of urokinase receptor in serum","volume":"52","author":"Piironen","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib16","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.thromres.2007.01.011","article-title":"Tissue factor and urokinase-type plasminogen activator system are related to the presence of cardiovascular disease in hemodialysis patients","volume":"120","author":"Pawlak","year":"2007","journal-title":"Thromb. Res."},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib17","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.thromres.2007.10.017","article-title":"The urokinase-type plasminogen activator\/its soluble receptor system is independently related to carotid atherosclerosis and associated with CC-chemokines in uraemic patients","volume":"122","author":"Pawlak","year":"2008","journal-title":"Thromb. Res."},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0741-5214(96)70152-0","article-title":"Influence of patient-related variables on the outcome of carotid endarterectomy","volume":"24","author":"Golledge","year":"1996","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib19","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJMoa002994","article-title":"Prognosis after transient monocular blindness associated with carotid-artery stenosis","volume":"345","author":"Benavente","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib20","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0140-6736(04)15785-1","article-title":"Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery","volume":"363","author":"Rothwell","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib21","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jvs.2005.08.009","article-title":"Carotid atherosclerotic plaques in patients with transient ischemic attacks and stroke have unstable characteristics compared with plaques in asymptomatic and amaurosis fugax patients","volume":"42","author":"Verhoeven","year":"2005","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib22","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1161\/CIRCULATIONAHA.105.589044","article-title":"Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study","volume":"113","author":"Redgrave","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1365-2796.2000.00716.x","article-title":"Attack rate, mortality and case fatality for acute myocardial infarction in Sweden during 1987\u201395. Results from the national AMI register in Sweden","volume":"248","author":"Rosen","year":"2000","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1148\/radiol.2231010575","article-title":"Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging","volume":"223","author":"Coakley","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib25","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.jacc.2005.02.058","article-title":"Act local, act global: inflammation and the multiplicity of \u201cvulnerable\u201d coronary plaques","volume":"45","author":"Libby","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib26","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.58.8.488","article-title":"Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritis","volume":"58","author":"Slot","year":"1999","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib27","first-page":"686","article-title":"The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau","volume":"6","author":"Eugen-Olsen","year":"2002","journal-title":"Int. J. Tuberc. Lung. Dis."},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.0300-9475.2005.01547.x","article-title":"Interleukin-6 infusion during human endotoxaemia inhibits in vitro release of the urokinase receptor from peripheral blood mononuclear cells","volume":"61","author":"Ostrowski","year":"2005","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib29","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1086\/428854","article-title":"Plasma concentrations of soluble urokinase-type plasminogen activator receptor are increased in patients with malaria and are associated with a poor clinical or a fatal outcome","volume":"191","author":"Ostrowski","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib30","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.clim.2009.01.007","article-title":"Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency","volume":"131","author":"Fevang","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clinbiochem.2009.09.028_bib31","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1046\/j.1523-1755.2003.00261.x","article-title":"Expression of urokinase plasminogen activator and its receptor during acute renal allograft rejection","volume":"64","author":"Roelofs","year":"2003","journal-title":"Kidney. Int."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991200900441X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991200900441X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:31:22Z","timestamp":1757863882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000991200900441X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":31,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S000991200900441X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2009.09.028","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble urokinase-type plasminogen activator receptor forms in plasma as markers of atherosclerotic plaque vulnerability","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2009.09.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}